Newsfeeds - Spark Newswire

1 minute read

Silence Therapeutics And Mallinckrodt Announce Submission Of Clinical Trial Application For SLN501; Silence To Receive $3M Milestone Payment

Today, 5:06 AM

Silence to receive $3 million research milestone payment from Mallinckrodt Phase 1 study expected to begin in the first half of 2022 LONDON & DUBLIN--(BUSINESS WIRE)-- Silence Therapeutics plc (NASDAQ:SLN), a

MNKKQ

1 minute read

Teva Suffers Loss In New York’s Opioid Trial

By Vandana Singh

Today, 5:06 AM

A jury in Suffolk County State Supreme Court found Teva Pharmaceutical Industries Ltd (NYSE: TEVA) contributed to New York's opioid epidemic.

ABBV

3 minute read

The Daily Biotech Pulse: Cellect Jumps On First Apograft Transplantation, AstraZeneca, European Commission Bury Legal Hatchet, Cassava Defends Itself

By Shanthi Rexaline

Today, 5:06 AM

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 2)

ABT

1 minute read

Mallinckrodt Wins FDA Approval For Its Regenerative Skin Burn Graft

By Vandana Singh

Today, 5:06 AM

Following four months of regulatory delays amid the COVID-19 pandemic, the FDA has finally approved Mallinckrodt Plc’s (OTC:MNKKQ) regenerative tissue graft…

MNKKQ